欢迎来到《四川大学学报(医学版)》

表现为肾病综合征的成人节段性膜性肾病1例报告及文献复习

姜毅

姜毅. 表现为肾病综合征的成人节段性膜性肾病1例报告及文献复习[J]. 四川大学学报(医学版), 2023, 54(3): 663-666. doi: 10.12182/20230560308
引用本文: 姜毅. 表现为肾病综合征的成人节段性膜性肾病1例报告及文献复习[J]. 四川大学学报(医学版), 2023, 54(3): 663-666. doi: 10.12182/20230560308
JIANG Yi. Adult Segmental Membranous Nephropathy Presenting As Nephrotic Syndrome: A Rare Case Report and Literature Review[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2023, 54(3): 663-666. doi: 10.12182/20230560308
Citation: JIANG Yi. Adult Segmental Membranous Nephropathy Presenting As Nephrotic Syndrome: A Rare Case Report and Literature Review[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2023, 54(3): 663-666. doi: 10.12182/20230560308

表现为肾病综合征的成人节段性膜性肾病1例报告及文献复习

doi: 10.12182/20230560308

Adult Segmental Membranous Nephropathy Presenting As Nephrotic Syndrome: A Rare Case Report and Literature Review

  • 摘要: 节段性膜性肾病(segmental membranous nephropathy, sMN)是一类罕见的肾脏病理类型,表现为IgG沿肾小球上皮下呈节段性颗粒样沉积。该病的临床表现多样,可表现为蛋白尿、肾病综合征或肾功能不全,也可继发于狼疮、肿瘤等多种疾病。本文报告了1例病理明确诊断为sMN而临床表现为肾病综合征的成人病例,并总结了国内外报道的总计87例成人sMN患者临床特点:成人sMN患者可单独出现或与其他肾小球或肾小管间质疾病同时出现,经常叠加在另一种主要疾病过程中,临床需首先排除继发性肾损害。
  • 图  1  患者肾脏病理光镜下可见基底膜节段性增厚(H&E ×400)

    Figure  1.  Segmental thickening of the basement membrane of the patient's kidney tissue can be seen under the light microscope (H&E ×400)

    图  2  患者肾脏病理免疫荧光示IgG2(A)、IgG3(B)节段性沿毛细血管襻呈细颗粒状沉积(×400)

    Figure  2.  Immunofluorescence of the patient's kidney tissue shows segmental deposition of IgG2 (A) and IgG3 (B) along the capillary loop in the form of fine granules (×400)

    图  3  患者肾脏病理电镜示肾小球基底膜节段性增厚(箭头a),节段性上皮下电子致密物沉积(箭头b)

    Figure  3.  Electron microscopy of the patient's kidney tissue shows segmental thickening of the glomerular basement membrane (indicated by the arrow a) and segmental deposition of subepithelial electron dense matter (arrow b)

  • [1] 祝爽爽, 王林, 江启锋, 等. 成人节段性膜性肾病1例. 实用医学杂志,2019,2: 337–338. doi: 10.3969/j.issn.1006-5725.2019.02.040
    [2] BECK L H, Jr, BONEGIO R G, LAMBEAU G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med,2009,361(1): 11–21. doi: 10.1056/NEJMoa0810457
    [3] REN S, WU C, ZHANG Y, et al. An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN. Ren Fail,2018,40(1): 306–313. doi: 10.1080/0886022X.2018.1456457
    [4] SETHI S, DEBIEC H, MADDEN B, et al. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney Int,2020,97(1): 163–174. doi: 10.1016/j.kint.2019.09.014
    [5] SETHI S, DEBIEC H, MADDEN B, et al. Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients. Kidney Int,2020,98(5): 1253–1264. doi: 10.1016/j.kint.2020.05.030
    [6] FOGO A B, LUSCO M A, NAJAFIAN B, et al. AJKD Atlas of renal pathology: membranous nephropathy. Am J Kidney Dis,2015,66(3): e15–17. doi: 10.1053/j.ajkd.2015.07.006
    [7] DUCROT H, TSOMI C, JUNGERS P, et al. Anatomoclinical study of extramembraneous glomerulonephritis. J Urol Nephrol (Paris),1969,75(9): 636–642.
    [8] KUDOSE S, SANTORIELLO D, DEBIEC H, et al. The clinicopathologic spectrum of segmental membranous glomerulopathy. Kidney Int,2021,99(1): 247–255. doi: 10.1016/j.kint.2020.06.014
    [9] KIM Y, BUTKOWSKI R, BURKE B, et al. Differential expression of basement membrane collagen in membranous nephropathy. Am J Pathol,1991,139(6): 1381–1388.
    [10] YAMAMOTO S, INABA S, YOSHIDA R, et al. Clinicopathological characteristics of the focal and segmental form of idiopathic membranous nephropathy: comparison with the typical form of this disease. Acta Paediatr Jpn,1997,39(3): 349–353. doi: 10.1111/j.1442-200x.1997.tb03751.x
    [11] CAZA T N, HASSEN S I, DVANAJSCAK Z, et al. NELL1 is a target antigen in malignancy-associated membranous nephropathy. Kidney Int,2021,99(4): 967–976. doi: 10.1016/j.kint.2020.07.039
    [12] SEGAWA Y, HISANO S, MATSUSHITA M, et al. IgG subclasses and complement pathway in segmental and global membranous nephropathy. Pediatr Nephrol,2010,25(6): 1091–1099. doi: 10.1007/s00467-009-1439-8
    [13] LARSEN C P, TRIVIN C, COLES P, et al. LDL receptor-related protein 2 (Megalin) as a target antigen in human kidney anti-brush border antibody disease. J Am Soc Nephrol,2018,29(2): 644–653. doi: 10.1681/ASN.2017060664
    [14] JENNETTE J, ISKANDAR S, DALLDORF F. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int,1983,24(3): 377–385. doi: 10.1038/ki.1983.170
    [15] ALEXANDER M P, LARSEN C P, GIBSON I W, et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int,2013,83(3): 455–462. doi: 10.1038/ki.2012.382
    [16] LARSEN C P, MESSIAS N C, SILVA F G, et al. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol,2013,26(5): 709–715. doi: 10.1038/modpathol.2012.207
    [17] CHOUNG H Y G, GOLDMAN B. Segmental membranous nephropathy. Clin Exp Nephrol,2021,25(7): 700–707. doi: 10.1007/s10157-021-02056-1
  • 加载中
图(3)
计量
  • 文章访问数:  15
  • HTML全文浏览量:  7
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-07-06
  • 修回日期:  2023-05-06
  • 网络出版日期:  2023-05-20
  • 刊出日期:  2023-05-20

目录

    /

    返回文章
    返回